Critical Innovations Hosts USAMMDA WEMT Development Partners

Critical Innovations welcomed visitors from the U.S. Army Medical Materiel Development Activity to its Los Angeles facility in July. USAMMDA’s Warfighter Expeditionary Medicine and Treatment Project Management Office leads the development and fielding of U.S. Food and Drug Administration-cleared or approved medical devices, drugs and biologics that fulfill unmet requirements identified by the U.S. Department of Defense end users. During the visit, the WEMT team reviewed the progress of two devices currently under development by Critical Innovations in two separate product areas: Burn Treatment and Skin Repair (BTSR) and Noncompressible Hemorrhage Control (NHC).

The WEMT team also visited Benchmark Biotech at the Legacy Research Institute in Portland, Oregon to learn about upcoming studies and evaluate medical technologies currently under development by Critical Innovations.

Critical Innovations’ Lead Prototype Technician, right, describes the company’s on-site prototyping capabilities to USAMMDA WEMT visitors.